Professor Michael BerkAlfred Deakin Chair of Psychiatry at Deakin University and Barwon Health
Michael Berk is an NHMRC Senior Principal Research Fellow, and is Alfred Deakin Chair of Psychiatry at Deakin University and Barwon Health, where he heads IMPACT, the Institute for Mental and Physical Health and Clinical Translation. On the bibliometric resource expertscape, he is ranked #1 in psychiatry globally, and in both depression and bipolar disorder, he is ranked 2nd globally and 1st in Australia. Nationally, between 2014-2019, CIA Berk was the top ranked author in citations in Australia for the FOR codes Psychology and Cognitive Sciences (SciVal) and 11th globally. He is past president of the International Society for Bipolar Disorders and the Australasian Society for Bipolar and Depressive Disorders. He is listed by Thompson Reuters as amongst the world’s most influential scientific minds (2015-2019), was awarded the Brain & Behaviour (NARSAD) Colvin Award for Mood Disorders in 2015, and Victoria Prize for Life Sciences in 2019 and the International Society for Bipolar Disorders Bob Post award for mentorship in 2020. He holds grants from the National Institutes of Health (US), Simon Autism Foundation, NHMRC CRE and Project Grants, Beyondblue, ARC Hub and Stanley Medical Research Institute and was a lead investigator in a Collaborative Research Centre. He generated $79M in total funding. His major interests are in the discovery and implementation of novel therapies.
2020 SCAP Presentation: Why might depression be increasing in our community, and what could we do about this? With a focus on the emergence of mental illness during adolescence